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Second, it is interesting that absolute
risk reduction in mortality from 23% to 6%
is 17% in those symptom-free patients who
were operated on. However, all variables in
a scientific study must be controlled except
the single variable that is being studied.
Thus, when David and colleagues1 at-
tempted to modify a successful operative
procedure, underlying background pathol-
ogies in the control and study groups
needed to be similar. This was lacking.
Third, the demographic data (Table1 in
the original article1) reveal an important
cause with regard to the population sample.
Atrial fibrillation (AF) was more prevalent
in the symptomatic than asymptomatic
group (P  .0001). Chronic AF carries
greater risk than intermittent AF, doubling
the risk of cardiovascular mortality. In
other words, implications for symptom-
free patients are only indirectly related, as
opposed to a direct cause-effect relation-
ship with AF.3 Moreover, diabetes mellitus
in the symptomatic group approached a
statistically significant difference (P 
.07). More recently, it has been shown that
all the patients with insulin-dependent dia-
betes mellitus with left diastolic dysfunc-
tion have evidence of definitive autonomic
neuropathy. Such isolated diastolic dys-
function may be the principal physiologic
mechanism in these patients. The annual
mortality from diastolic heart failure varies
widely, from 9% to 28%,4 This variable
should be addressed in the context of pa-
tient cohort by reviewing echocardio-
graphic evidence of diastolic dysfunction.
The mortality rate among patients with di-
astolic heart failure is 4 times that among
persons without heart failure but half that
among patients with systolic heart failure.
Third, apart from the semantics of
asymptomatic, of more interest at mean
follow-up 93% of patients in the asymp-
tomatic group were in New York Heart
Association (NYHA) functional class I or
II, which was not statistically significant
from the symptomatic group (88%). This
result argues that mitral valve surgery re-
pair on symptom-free patients does not
confer any further clinical benefit. This sta-
tistic is consistent with others and follows
classic teachings. Also, the discrepancy be-
tween the reoperation rate and the inci-
dence of significant mitral valve regurgita-
tion indicates that not all patients having
important valve incompetence late after re-
pair undergo surgery again within the time
frame. This repeated observation creates a
new argument that recurrent mitral incom-
petence lacks substance as an indication for
operation and argues against the primary
hypothesis and conclusion of David and
colleagues.1
Fourth, David and colleagues1 did not
mention the well-known limitations to the
simple NYHA scale for cardiovascular dis-
ability. NYHA has a tendency to oversim-
plify an issue or a problem by ignoring
complexities or complications. The criteria
committee of the NYHA has provided a
widely used classification that relates
symptoms to “ordinary” activity. The term
ordinary is subject to various interpreta-
tions, as are terms such as undue fatigue.
Such terms have limited the accuracy and
reproducibility of the NYHA classification.5
In the end, it is desirable to seek patients
who need an operation. Offering such sur-
gery to symptom-free patients on the basis
of effect rather than cause, however, is
simplistic and fuzzy. Better data analytic
methodology and study design are needed
to qualify for a new indication.
Jeffrey H. Shuhaiber, MD
Department of Surgery
University of Illinois at Chicago
Chicago, IL 60612
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Reply to the Editor:
Dr Shuhaiber makes some valid points
about our study,1 but many of his com-
ments are irrelevant. He ignored the fact
that ours was an observational study and
did not establish causation but rather an
association between functional class and
late mortality after mitral valve repair for
mitral regurgitation caused by prolapse.
The objectives of the study were clearly
defined, and in addition to showing the late
outcomes of mitral valve repair for floppy
valves it also showed associations between
certain preoperative variables and late mor-
tality by multivariable analysis with boot-
strap validation. Our study was not a pro-
spective randomized trial, and consequently
we could not control the variables before the
operation as he suggested. This is, of course,
a major limitation of all retrospective studies.
One can only adjust for those factors that
were measured. Residual confounding by un-
measured variables may potentially distort
results. However, numerous studies have
shown that careful, multivariable analysis of
observational data produces treatment effects
very similar to those of randomized con-
trolled trials.2-4
Atrial fibrillation and diabetes were in-
cluded in all multivariable models. Dr Shu-
haiber’s concerns regarding chronic atrial
fibrillation may in fact provide further ar-
gument to operate on symptom-free pa-
tients. Atrial fibrillation may be a conse-
quence of deterioration in ventricular
function in patients with mitral regurgita-
tion, and by the time it first occurs irrevers-
ible changes may already be present.
His remarks regarding postoperative
functional class and the probability of re-
current mitral regurgitation in our patients
are incorrect. One would not expect symp-
tom-free patients to have lessened symp-
toms after the operation simply because
they were already in functional classes 1
and 2 (ceiling effect). The analysis at fol-
low-up was designed to demonstrate the
improvement in the patients with symp-
toms. The mechanism of mitral valve pro-
lapse was similar in both groups of pa-
tients, and recurrent mitral regurgitation
after mitral valve repair is more dependent
on the pathology of the mitral valve than on
presence or absence of preoperative symp-
toms. That is reason why recurrent mitral
regurgitation and reoperation rates were
similar in the two groups.
We agree that functional class is a soft,
subjective variable, especially between
classes 2 and 3, but certainly not between
classes 1 and 3 or 2 and 4. Moreover,
symptoms are usually the reason a patient
seeks medical advice. What our study
showed is that postponing surgery until
symptoms are more obvious (functional
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classes 3 and 4) is not appropriate if the
mitral valve can be repaired. Nowhere in
the text of our article will the reader find a
sentence stating, “Patients with asymptom-
atic mitral valve incompetence are candi-
dates for surgery,” as written in Dr Shu-
haiber’s letter. In fact, in the last paragraph
in the discussion of our article, the reader
will find the following1: “In conclusion,
surgical intervention should be considered
in asymptomatic patients with severe MR
caused by floppy valves if valve repair is
feasible, and it can be done with low oper-
ative mortality and morbidity because the
late survival is identical to that of the gen-
eral population.”
And the paragraph before the last reads
as follows1: “This is a retrospective study
of a clinical experience of a single surgeon,
and the results might to be generalizable.
The prevalence of associated cardiac and
non-cardiac diseases was relatively small
in this series, and statistical values of cer-
tain variables might have been altered by
chance alone.”
We believe our conclusion was far
softer than implied in the letter. However,
we agree that a controlled randomized trial
is needed to determine the appropriateness
of mitral valve repair for symptom-free pa-
tients with normal left ventricular function.
Tirone E. David, MD
Joan Ivanov, PhD
Susan Armstrong, MSc
Harry Rakowski, MD
Division of Cardiovascular Surgery
Toronto General Hospital and
University of Toronto
Toronto, Ontario, Canada
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Esophageal perforation during left
atrial radiofrequency ablation
To the Editor:
Doll and colleagues1 reported an esopha-
geal perforation incidence of 1% (4/387)
after left atrial ablation with intraoperative
radiofrequency ablation for atrial fibrilla-
tion. Risk factors could not be identified;
therefore, they recommended against the
use of intraoperative radiofrequency abla-
tion for atrial fibrillation. In our opinion,
however, a combination of various fac-
tors—such the device, the handling of de-
vice, the application time, the lesion pat-
tern, and the surgical access—contribute to
this complication, rather than the mere use
of radiofrequency.
Doll and colleagues1 used temperature-
controlled radiofrequency ablation with a
10-mm T-shaped rigid ablation probe (Ra-
dios 504; Osypka GmbH, Grenzach,
Wyhlen, Germany) targeting a temperature
of 60°C for 20 seconds for each lesion
without taking the variability of the local
atrial wall thickness into account. This
catheter has a temperature overshoot,
which proved to be a concern in terms of
safety and rapidity of feedback control. Ex-
cessive tissue temperature could result in
necrotic perforation.2 It is the overlap be-
tween two linear ablation lines where ex-
cessive tissue heating can occur. The
Leipzig group did not mention this in their
publication. The Leipzig group performed
these procedures through a right lateral
minithoracotomy; therefore, dissection of
the doom of the left atrium was probably
not done. Thus the relation ship between
the left atrium and the esophagus was in-
tense.
Several surgical centers have used tem-
perature-controlled radiofrequency without
reporting any esophageal or circumflex ar-
terial injuries (Table 1). However, differ-
ences in technique can be distinguished.
All centers used a standard sternotomy.
Williams and coworkers4 used a flexible
ablation probe with seven consecutive elec-
trodes (Cobra; Boston Scientific–EP
Technologies, La Garenne Colombes,
France), each independently regulated by
the generator targeting an even higher
temperature (70°C-80°C) and longer ap-
plication time (1 minute) per lesion than
used by Doll and colleagues.1 Energy
delivery was flexible but still up to 150
W. Ablation lesions were either made as
separate ovals around the left and right
orifices or as a complete circumferential
island around all four pulmonary orifices.
Nevertheless, Williams and coworkers4
did not report any injury, nor did Benussi
and associates5 and Melo and col-
leagues,6 who also used temperature-con-
trolled radiofrequency in a combined co-
hort of 105 patients.
In our own series of 124 patients treated
with irrigated radiofrequency,9 the 30-day
mortality was 4.8% (6/124). The causes of
death were cerebral stroke (n  1), atrio-
ventricular dehiscence (n 1), cardiac fail-
ure (n  1), and low cardiac output (n 
3). Autopsies did not reveal any esopha-
geal, pulmonary orifice, or circumflex arte-
rial injuries. Neither were such injuries
seen by Sie and coworkers7 in a series of
122 patients. We used a handheld, flexible
pen catheter (Cardioblate; Medtronic Inc,
Minneapolis, Minn). Formation of yellow-
white blistering endocardial lesions, in-
duced by oscillating catheter movements,
were considered sufficient. Stable catheter-
tissue contact was preserved without press-
ing the atrial wall against adjacent medias-
tinal structures.
We therefore believe that the cause of
the reported complication was the use of a
rigid T-shaped temperature-controlled ra-
diofrequency ablation probe pressed
against the atrial wall, which was not dis-
TABLE 1. Results of selected series
Reference
Esophageal
injury
Circumplex
arterial injury
Sinus rhythm
(%)
30-d Mortality
(%)
Mohr et al3 1% (4/387) 0.4% (1/234) 67–78 6.4 (15/234)
Williams et al4 81 12.5 (6/48)
Benussi et al5 77 2.5 (1/40)
Melo et al6 54 0 (0/65)
Sie et al7 72 4.1 (5/122)
Gueden et al8 71–95 3.2 (2/62)
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